In vitro activation of dacarbazine (DTIC) for a human tumor cloning system
- 2 January 1983
- journal article
- research article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 1 (1) , 24-32
- https://doi.org/10.1002/stem.5530010105
Abstract
Dacarbazine (DTIC) is an agent with clinical activity against human malignant melanoma. We have explored two methods for activating DTIC so it may be used in vitro in a human tumor cloning system. The activation of DTIC by white light was found to be a viable alternative to utilizing a microsome plus cofactor system for bioactivation. The microsome plus cofactor system itself actually caused some inhibition of tumor colony formation. Light activation of DTIC appears to be a reliable and simple method which allows testing of DTIC in an in vitro soft agar culture system.Keywords
This publication has 11 references indexed in Scilit:
- Direct cloning of human malignant melanoma in soft agar cultureCancer, 1982
- Primary Bioassay of Human Myeloma Stem CellsJournal of Clinical Investigation, 1977
- Primary Bioassay of Human Tumor Stem CellsScience, 1977
- Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity testMutation Research/Environmental Mutagenesis and Related Subjects, 1975
- Method for tissue culture evaluation of the cytoxic activity of drugs active through the formation of metabolitesPublished by Elsevier ,1973
- Mechanism of action of 5-(3,3-dimethyl-1-triazeno)imidazole-4-caboxamide in mammalian cells in cultureBiochemical Pharmacology, 1972
- Role of 4-diazoimidazole-5-carboxamide in the action of the antitumor agent 5(4)-(3,3-dimethyl-1-triazeno) imidazole-4-(5)carboxa-mide in Bacillus subtilisBiochemical Pharmacology, 1972
- Studies of the mechanism of action of the antitumor agent 5(4)-(3,3-dimethyl-1-triazeno) imidazole-4(5)-carboxamide in Bacillus subtilisBiochemical Pharmacology, 1970
- 4 (or 5)-diazoimidazole-5 (or 4)-carboxamide and related triazenoimidazoles as antibacterial agents: Their effects on nucleic acid metabolism of Escherichia coli BBiochemical Pharmacology, 1969
- Mechanism of carcinogenesis with 1-Aryl-3,3-dialkyltriazenes. Enzymatic dealkylation by rat liver microsomal fraction in vitroBiochemical Pharmacology, 1969